ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $59,521,102 | +122.8% | 2,290,154 | +145.2% | 0.02% | +88.9% |
Q1 2024 | $26,709,540 | -8.2% | 933,900 | -1.8% | 0.01% | -18.2% |
Q4 2023 | $29,109,596 | +46.2% | 951,294 | +28.4% | 0.01% | +22.2% |
Q3 2023 | $19,907,498 | +46.0% | 740,882 | +38.0% | 0.01% | +28.6% |
Q2 2023 | $13,638,911 | 0.0% | 536,965 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $13,638,911 | -32.5% | 536,965 | +7.8% | 0.01% | -36.4% |
Q4 2022 | $20,195,676 | -99.3% | 497,921 | +476.6% | 0.01% | +450.0% |
Q3 2022 | $2,854,199,000 | -26.1% | 86,360 | -21.3% | 0.00% | 0.0% |
Q2 2022 | $3,863,417,000 | -26.2% | 109,725 | -3.7% | 0.00% | 0.0% |
Q1 2022 | $5,237,617,000 | -18.6% | 113,886 | +17.3% | 0.00% | 0.0% |
Q4 2021 | $6,438,325,000 | +4.7% | 97,109 | -1.4% | 0.00% | -33.3% |
Q3 2021 | $6,148,856,000 | -15.3% | 98,492 | +12.4% | 0.00% | 0.0% |
Q2 2021 | $7,260,085,000 | +19.7% | 87,661 | -4.2% | 0.00% | 0.0% |
Q1 2021 | $6,064,778,000 | -32.8% | 91,461 | -22.2% | 0.00% | -25.0% |
Q4 2020 | $9,023,140,000 | +97.5% | 117,596 | +10.8% | 0.00% | +100.0% |
Q3 2020 | $4,569,484,000 | +0.6% | 106,119 | +0.9% | 0.00% | -33.3% |
Q2 2020 | $4,542,465,000 | +77.6% | 105,174 | +18.3% | 0.00% | +50.0% |
Q1 2020 | $2,557,566,000 | -55.2% | 88,897 | -1.3% | 0.00% | -33.3% |
Q4 2019 | $5,714,663,000 | +122.5% | 90,094 | -1.1% | 0.00% | +50.0% |
Q3 2019 | $2,568,071,000 | +25.3% | 91,131 | +17.9% | 0.00% | +100.0% |
Q2 2019 | $2,048,902,000 | +171.2% | 77,317 | +87.8% | 0.00% | 0.0% |
Q1 2019 | $755,561,000 | +10.1% | 41,175 | -25.5% | 0.00% | 0.0% |
Q4 2018 | $686,378,000 | -46.8% | 55,264 | -17.8% | 0.00% | 0.0% |
Q3 2018 | $1,289,489,000 | +93.2% | 67,266 | +37.0% | 0.00% | 0.0% |
Q2 2018 | $667,515,000 | +443.4% | 49,082 | -26.1% | 0.00% | – |
Q1 2017 | $122,840,000 | +614100.0% | 66,400 | +414.7% | 0.00% | – |
Q4 2016 | $20,000 | -88.6% | 12,900 | -45.8% | 0.00% | – |
Q3 2016 | $175,000 | +37.8% | 23,800 | 0.0% | 0.00% | – |
Q2 2016 | $127,000 | +10.4% | 23,800 | 0.0% | 0.00% | – |
Q1 2016 | $115,000 | – | 23,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |